This site is intended for healthcare professionals

Keytruda plus chemotherapy reduced risk of death by 27% versus chemotherapy as first-line treatment for locally advanced or metastatic esophageal cancer.- Merck Inc.

Read time: 4 mins
Last updated:25th Sep 2020
Published:26th Sep 2020
Condition: Oesophageal Cancer
Type: drug
Register free for full access to